PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2026Haematologica0 citationsOpen Access

High-cholesterol diet fuels myeloma progression, dysregulates adipokine expression in vivo, and impairs treatment response ex vivo

View Full Paper
BGBeatriz GámezUniversity of OxfordDWDanielle WhippUniversity of OxfordSRSrinivasa R. RaoUniversity of Oxford

Key Points

  • To investigate how a high-cholesterol diet affects myeloma progression and treatment response.
  • Administered high-cholesterol diet in myeloma models in vivo.
  • Evaluated adipokine expression levels.
  • Assessed treatment responses ex vivo.
  • High-cholesterol diet accelerated myeloma progression.
  • Adipokine expression was significantly altered.
  • Treatment responses were negatively impacted by diet.

Abstract

Not available.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gámez et al. (2026) studied this question.

synapsesocial.com/papers/699011932ccff479cfe5861ehttps://doi.org/10.3324/haematol.2025.288286
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease2011 · 136 citations
  2. 2Cholesterol metabolism reprogramming: shaping tumor immunity and immunotherapy2026
  3. 3A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model2025 · 12 citations
  4. 4Targeting cholesterol-driven immunometabolism in cancer: from molecular circuits to clinical translation2026
  5. 5Abstract 4423: Cholesterol and arachidonic acid promote the tumor growth of epithelial ovarian cancer via MAPK signaling pathway2024